• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC AG (JENA) VISUMAX; FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC AG (JENA) VISUMAX; FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION Back to Search Results
Catalog Number 000000-1345-518
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Edema (1791); Visual Impairment (2138); Insufficient Information (4580)
Event Date 04/24/2022
Event Type  Injury  
Event Description
On (b)(6) 2022, the doctor was working on a lasik procedure with visumax.After opening the flap the surgeon found an irregular cut in the stromal bed (central corneal island / button).The next procedure (eximer laser) was not continued.The patient was sent home.
 
Manufacturer Narrative
Investigation result summary: on march 28th, 2022, a flap procedure was performed on a patient with the visumax system.The corneal cutting procedure was interrupted during the flap cut and error 0x6122 was displayed on the visumax screen.The incision was not completed, and the patient was sent home.· an interruption of the treatment during a flap cut does not affect the visual acuity.There is no visual effect until tissue evaporates.Since in this case the flap was not lifted, and the inner corneal tissue was not reshaped by the excimer laser (tissue evaporates), there was no impact on the visual acuity of the patient.· in general, treatment interruption can happen due to different reasons e.G., suction loss, power failure, equipment malfunction or discomfort of the patient or doctor.An immediate restart of the surgery or a transformation to alternative excimer laser treatments can be helpful depending on the surgical step at which it occurs.Restart of flap treatment and aspects that require additional attention as well as further safety and warning instructions are described in the user manual (000000-1345-518-doks-fp-cz-1102141).· the displayed error 0x6122 indicates a scan control signal scan error.The device log file indicates that on the same day further flap surgeries have been completed successfully.A replacement of the scanner cable set by zeiss service on april 1st, 2022, solved this issue.On (b)(6) 2022, the patient was retreated.The laser settings were the same as for the first treatment in march.After opening the flap, the surgeon found significant irregularities in the central area of the cornea (central corneal island / button) and the subsequent procedure to reshape the cornea with the excimer laser was not carried out.The patient was sent home.· the described "central corneal button" can be assigned to the known side effect "disorders of cornea" and could cause visual impairments.A different cutting depth, e.G., due to regrowing epithelium, might have caused the described side effect.Our investigation has revealed that the initial flap treatment was interrupted by a scanner error and the patient was retreated with a flap treatment four weeks later, which is classified as a contraindication.The treatment should have been resumed immediately after the previous treatment phase was interrupted.A device inspection was performed.No safety or functional deficiencies were detected; functional checks successfully completed.According to the available information the root cause is a use error, which is neither due to ergonomic features, nor due to any inadequacy in the information supplied by the manufacturer.Section h6 - health effect clinical code: changed from 4580 (insufficient information) to 1791 (corneal edema); and 2138 (visual impairment); -health effect impact code: changed from 4648 (insufficient information), to 4610 (inadequate/inappropriate treatment or diagnostic exposure); 4635 unexpected deterioration; -type of investigation: added 10, testing of actual/suspected device; 4112 (analysis of data provided by user/third party); -investigation findings: changed from 3233 (results pending completion of investigation) to 4248, usage problem identified; 213, no device problem found; -investigation conclusions: changed from 11 (conclusion not yet available) to 19 (cause traced to user).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISUMAX
Type of Device
FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION
Manufacturer (Section D)
CARL ZEISS MEDITEC AG (JENA)
carl zeiss promenade 10
jena, thueringia 07745
GM  07745
Manufacturer (Section G)
CARL ZEISS MEDITEC AG (JENA)
carl zeiss promenade 10
jena, thueringia 07745
GM   07745
Manufacturer Contact
manjaya hegde
5300 central parkway
dublin, CA 94568
9252164697
MDR Report Key14735554
MDR Text Key294401409
Report Number9615030-2022-00005
Device Sequence Number1
Product Code OTL
Combination Product (y/n)N
Reporter Country CodeEZ
PMA/PMN Number
P150040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/17/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number000000-1345-518
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/30/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-